Clinical Trials Logo

Clinical Trial Summary

The aim of the study is twofold: 1) to evaluate an Relaps Prevention(RP) treatment for Problematic Gaming (PG) and Internet Gaming Disorder (IGD) patients recruited from child and youth psychiatry (CAP) clinics and 2) to test whether the quality of parent-child relationships plays role in the effect of RP treatment and vice versa - whether the RP treatment has a spillover effect on the quality of parent-child relationships.


Clinical Trial Description

This study is a two-arm, parallel-group, single-blind, early-stage Randomized Clinical Trial (RCT) with embedded qualitative components. Participants will be randomized in a 1:1 ratio to either intervention or control, with a total of 162 participants (81+81) in the trial. The primary outcomes are measures of gaming and gambling behavior pre- and post-intervention, and the secondary outcomes include child ratings of parent-child communication, including parental knowledge, control and solicitousness about child gaming, as well as child disclosure and secrecy related to gaming. Preliminary analyses will be conducted with regression analyses, paired sample t-tests and ANOVAs and performed in Mplus. In addition to the RCT, the study will be supplemented with a qualitative component with semi-structured individual interviews to capture participants' and clinicians' experiences of the treatment, as well as attitudes about parent-child relationships and parenting needs in carers whose children completed the RP treatment. The qualitative data will be analyzed with thematic analysis. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT05506384
Study type Interventional
Source Region Skane
Contact
Status Completed
Phase N/A
Start date May 1, 2021
Completion date December 31, 2023

See also
  Status Clinical Trial Phase
Completed NCT02590211 - Poker, Skills and Associated Problems N/A
Completed NCT02203786 - D1 and D2 Dopamine Receptors in Gambling and Amphetamine Reinforcement Phase 2
Completed NCT05051085 - Feasibility of the Internet-delivered Treatment "SpilleFri" for Patients With Pathological Gambling N/A
Completed NCT01215357 - Clinical Study to Determine if Ecopipam Can Reduce Urges to Gamble Phase 2
Terminated NCT00245583 - Topiramate in the Treatment of Pathological Gambling Phase 3
Completed NCT04842461 - Mental Health, Addictions and Biomarkers in High Athletes Performance
Not yet recruiting NCT03280966 - Effects of Intranasal Naloxone on Gambling Urges in Gambling Disorder Phase 2
Active, not recruiting NCT01743092 - Testing Resources: Manual and Webinar Guided Treatment vs. Manual Guided Treatment N/A
Active, not recruiting NCT01528982 - Susceptibility to Pathological Gambling N/A
Terminated NCT00211822 - Functional Magnetic Resonance Imaging (fMRI) Studies in Pathological Gambling (PG) and Obsessive-Compulsive Disorder (OCD) N/A
Completed NCT01381250 - Effects of Internet-based Treatment of Pathological Gambling N/A
Enrolling by invitation NCT03464838 - Effects of Transcranial Direct Current Stimulation (tDCS) in Gambling Disorder N/A
Terminated NCT01560351 - Repeated Low-frequency Transcranial Magnetic Stimulation Reduces Cue-induced Craving: a Randomized, Prospective, Double-blind, Sham-controlled, Cross-over Study N/A
Completed NCT00580567 - Impulsivity in Pathological Gambling N/A
Completed NCT02240485 - Integrative Couple Treatment for Pathological Gambling N/A
Withdrawn NCT01340274 - Community Reinforcement Approach and Family Training (CRAFT) for Problem Gambling Phase 2
Recruiting NCT02491996 - The Efficacy of Therapy Focused on Desire-satisfaction for Disordered Gamblers N/A
Recruiting NCT01154712 - Deep Low-Frequency Repetitive Transcranial Magnetic Stimulation for Cessation of Pathological Gambling Phase 1
Completed NCT01843699 - Topiramate Trial for Pathological Gamblers Phase 2
Completed NCT00927563 - Tolcapone Treatment of Pathological Gambling Phase 2